Epigenetic therapy worth pursuing in hormone receptor positive advanced breast cancer
Credit: © European Society for Medical Oncology Munich, Germany, 20 October 2018 - Epigenetic therapy with histone deacetylase (HDAC) inhibitors is worth pursuing in hormone...






